Igor Matushansky's most recent trade in Immuneering Corp - Ordinary Shares Class A was a trade of 118,000 Stock Option done . Disclosure was reported to the exchange on March 21, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immuneering Corp (Class A) | Igor Matushansky | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2025 | 118,000 | 118,000 | - | - | Stock Option | |
| Hookipa Pharma Inc | Igor Matushansky | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 92,950 | 92,950 | - | - | Stock Option (Right to Buy) | |
| Hookipa Pharma Inc | Igor Matushansky | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Apr 2022 | 92,950 | 92,950 | - | - | Stock Option (Right to Buy) | |
| Hookipa Pharma Inc | Igor Matushansky | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 24,888 | 24,888 | - | - | Stock Option (Right to Buy) | |
| Hookipa Pharma Inc | Igor Matushansky | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 3.00 per share. | 01 Feb 2022 | 14,933 | 100,240 (0%) | 0% | 3 | 44,799 | Common Stock |
| Hookipa Pharma Inc | Igor Matushansky | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Apr 2021 | 95,250 | 95,250 | - | - | Stock Option (Right to Buy) |